Form 4 ABEONA THERAPEUTICS INC. For: Nov 07 Filed by: Wider Todd
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Abeona Therapeutics (ABEO) Tops Q3 EPS by 11c
November 10, 2016 7:45 AM ESTAbeona Therapeutics (NASDAQ: ABEO) reported Q3 EPS of ($0.08), $0.11 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $184 thousand versus the consensus estimate of $240 thousand.
Cash, cash equivalents and marketable securities as of September 30, 2016 were $31.2 million, compared to $34.3 million... More
